Curzerene Suppresses Hepatocellular Carcinoma Progression Through the PI3K/AKT/MTOR Pathway

ABSTRACT Background: Hepatocellular carcinoma (HCC) is one of the most aggressive cancers worldwide. Curzerene is a sesquiterpene and component of Curcuma rhizomes and has anti-tumor and anti-inflammatory properties. Objective: The study aimed to investigate the effects of curzerene on the malignant phenotypes and tumor growth in HCC. Methods: Various concentrations of curzerene were used to treat human HCC cells (Huh7 and HCCLM3). Cell viability, apoptosis, cell cycle, invasion, and migration were detected by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, flow cytometry, Transwell, and wound healing assays. Cell cycle-, apoptosis-, and signaling pathway-related proteins were analyzed by Western blot analysis. A mouse xenograft model was established to analyze the anti-tumor effects of curzerene in vivo. Results: Curzerene repressed the proliferation, invasion, and migration of Huh7 and HCCLM3 cells. Curzerene also induced G2/M cycle arrest and cell apoptosis. Curzerene downregulated the CDK1, cyclin B1, PCNA, Bcl-2, matrix metallopeptidases (MMP)2, and MMP9 protein expression and upregulated the Bax, cleaved caspase3, and cleaved poly ADPribose polymerase protein expression in HCC cells. Curzerene restrained the phosphorylation of PI3K, AKT, and the Mammalian target of rapamycin (mTOR) in Huh7 and HCCLM3 cells. The in vivo data revealed that curzerene inhibited HCC tumor growth and decreased the expression of phosphorylated mTOR in xenograft mouse models. Conclusion: Curzerene inhibited cell malignancy in vitro and tumor growth in vivo in HCC, suggesting that curzerene may be a candidate agent for anti-HCC therapy. (REV INVEST CLIN. 2024;76(4):173-84)

Saved in:
Bibliographic Details
Main Authors: Luo,Yihui, Wang,Zhenchang, Jiang,Jun´e, Wu,Shanshan, Zhai,Yang
Format: Digital revista
Language:English
Published: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán 2024
Online Access:http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762024000400173
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0034-83762024000400173
record_format ojs
spelling oai:scielo:S0034-837620240004001732025-01-17Curzerene Suppresses Hepatocellular Carcinoma Progression Through the PI3K/AKT/MTOR PathwayLuo,YihuiWang,ZhenchangJiang,Jun´eWu,ShanshanZhai,Yang Hepatocellular carcinoma Curzerene Cell cycle MMP9 mTOR ABSTRACT Background: Hepatocellular carcinoma (HCC) is one of the most aggressive cancers worldwide. Curzerene is a sesquiterpene and component of Curcuma rhizomes and has anti-tumor and anti-inflammatory properties. Objective: The study aimed to investigate the effects of curzerene on the malignant phenotypes and tumor growth in HCC. Methods: Various concentrations of curzerene were used to treat human HCC cells (Huh7 and HCCLM3). Cell viability, apoptosis, cell cycle, invasion, and migration were detected by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, flow cytometry, Transwell, and wound healing assays. Cell cycle-, apoptosis-, and signaling pathway-related proteins were analyzed by Western blot analysis. A mouse xenograft model was established to analyze the anti-tumor effects of curzerene in vivo. Results: Curzerene repressed the proliferation, invasion, and migration of Huh7 and HCCLM3 cells. Curzerene also induced G2/M cycle arrest and cell apoptosis. Curzerene downregulated the CDK1, cyclin B1, PCNA, Bcl-2, matrix metallopeptidases (MMP)2, and MMP9 protein expression and upregulated the Bax, cleaved caspase3, and cleaved poly ADPribose polymerase protein expression in HCC cells. Curzerene restrained the phosphorylation of PI3K, AKT, and the Mammalian target of rapamycin (mTOR) in Huh7 and HCCLM3 cells. The in vivo data revealed that curzerene inhibited HCC tumor growth and decreased the expression of phosphorylated mTOR in xenograft mouse models. Conclusion: Curzerene inhibited cell malignancy in vitro and tumor growth in vivo in HCC, suggesting that curzerene may be a candidate agent for anti-HCC therapy. (REV INVEST CLIN. 2024;76(4):173-84)info:eu-repo/semantics/openAccessInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránRevista de investigación clínica v.76 n.4 20242024-08-01info:eu-repo/semantics/articletext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762024000400173en10.24875/ric.24000018
institution SCIELO
collection OJS
country México
countrycode MX
component Revista
access En linea
databasecode rev-scielo-mx
tag revista
region America del Norte
libraryname SciELO
language English
format Digital
author Luo,Yihui
Wang,Zhenchang
Jiang,Jun´e
Wu,Shanshan
Zhai,Yang
spellingShingle Luo,Yihui
Wang,Zhenchang
Jiang,Jun´e
Wu,Shanshan
Zhai,Yang
Curzerene Suppresses Hepatocellular Carcinoma Progression Through the PI3K/AKT/MTOR Pathway
author_facet Luo,Yihui
Wang,Zhenchang
Jiang,Jun´e
Wu,Shanshan
Zhai,Yang
author_sort Luo,Yihui
title Curzerene Suppresses Hepatocellular Carcinoma Progression Through the PI3K/AKT/MTOR Pathway
title_short Curzerene Suppresses Hepatocellular Carcinoma Progression Through the PI3K/AKT/MTOR Pathway
title_full Curzerene Suppresses Hepatocellular Carcinoma Progression Through the PI3K/AKT/MTOR Pathway
title_fullStr Curzerene Suppresses Hepatocellular Carcinoma Progression Through the PI3K/AKT/MTOR Pathway
title_full_unstemmed Curzerene Suppresses Hepatocellular Carcinoma Progression Through the PI3K/AKT/MTOR Pathway
title_sort curzerene suppresses hepatocellular carcinoma progression through the pi3k/akt/mtor pathway
description ABSTRACT Background: Hepatocellular carcinoma (HCC) is one of the most aggressive cancers worldwide. Curzerene is a sesquiterpene and component of Curcuma rhizomes and has anti-tumor and anti-inflammatory properties. Objective: The study aimed to investigate the effects of curzerene on the malignant phenotypes and tumor growth in HCC. Methods: Various concentrations of curzerene were used to treat human HCC cells (Huh7 and HCCLM3). Cell viability, apoptosis, cell cycle, invasion, and migration were detected by 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, flow cytometry, Transwell, and wound healing assays. Cell cycle-, apoptosis-, and signaling pathway-related proteins were analyzed by Western blot analysis. A mouse xenograft model was established to analyze the anti-tumor effects of curzerene in vivo. Results: Curzerene repressed the proliferation, invasion, and migration of Huh7 and HCCLM3 cells. Curzerene also induced G2/M cycle arrest and cell apoptosis. Curzerene downregulated the CDK1, cyclin B1, PCNA, Bcl-2, matrix metallopeptidases (MMP)2, and MMP9 protein expression and upregulated the Bax, cleaved caspase3, and cleaved poly ADPribose polymerase protein expression in HCC cells. Curzerene restrained the phosphorylation of PI3K, AKT, and the Mammalian target of rapamycin (mTOR) in Huh7 and HCCLM3 cells. The in vivo data revealed that curzerene inhibited HCC tumor growth and decreased the expression of phosphorylated mTOR in xenograft mouse models. Conclusion: Curzerene inhibited cell malignancy in vitro and tumor growth in vivo in HCC, suggesting that curzerene may be a candidate agent for anti-HCC therapy. (REV INVEST CLIN. 2024;76(4):173-84)
publisher Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
publishDate 2024
url http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0034-83762024000400173
work_keys_str_mv AT luoyihui curzerenesuppresseshepatocellularcarcinomaprogressionthroughthepi3kaktmtorpathway
AT wangzhenchang curzerenesuppresseshepatocellularcarcinomaprogressionthroughthepi3kaktmtorpathway
AT jiangjune curzerenesuppresseshepatocellularcarcinomaprogressionthroughthepi3kaktmtorpathway
AT wushanshan curzerenesuppresseshepatocellularcarcinomaprogressionthroughthepi3kaktmtorpathway
AT zhaiyang curzerenesuppresseshepatocellularcarcinomaprogressionthroughthepi3kaktmtorpathway
_version_ 1822281051653799936